{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:57:28Z","timestamp":1791640648102,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81600899"],"award-info":[{"award-number":["81600899"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81702695"],"award-info":[{"award-number":["81702695"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772888"],"award-info":[{"award-number":["81772888"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.biopha.2017.11.024","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T02:04:28Z","timestamp":1510711468000},"page":"1341-1348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Cancer-associated \ufb01broblasts confer cisplatin resistance of tongue cancer via autophagy activation"],"prefix":"10.1016","volume":"97","author":[{"given":"Juan-kun","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-mei","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-lin","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2017.11.024_bib0005","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/bjc.2013.770","article-title":"Akt\/Ezrin Tyr353\/NF-kappaB pathway regulates EGF-induced EMT and metastasis in tongue squamous cell carcinoma","volume":"110","author":"Wang","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2017.11.024_bib0010","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/onc.2011.263","article-title":"MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1","volume":"31","author":"Sun","year":"2012","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.biopha.2017.11.024_bib0015","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/jop.12172","article-title":"A role for cancer-associated fibroblasts in inducing the epithelial-to-mesenchymal transition in human tongue squamous cell carcinoma","volume":"43","author":"Zhou","year":"2014","journal-title":"J. Oral Pathol. Med."},{"issue":"6","key":"10.1016\/j.biopha.2017.11.024_bib0020","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1007\/s10147-016-0997-6","article-title":"Phase II study of docetaxel, cisplatin, and concurrent radiation followed by platinum-based adjuvant chemotherapy for technically unresectable, locally advanced head and neck squamous cell carcinoma","volume":"21","author":"Nakahara","year":"2016","journal-title":"Int. J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2017.11.024_bib0025","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1200\/JCO.2012.43.8820","article-title":"Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma","volume":"31","author":"Zhong","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"15","key":"10.1016\/j.biopha.2017.11.024_bib0030","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1200\/JCO.2005.01.057","article-title":"Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group","volume":"23","author":"Gibson","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.024_bib0035","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/carcin\/bgw113","article-title":"Cancer-associated fibroblasts regulate keratinocyte cell-cell adhesion via TGF-beta-dependent pathways in genotype-specific oral cancer","volume":"38","author":"Cirillo","year":"2017","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biopha.2017.11.024_bib0040","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.30801","article-title":"Cancer-associated fibroblast-derived Lumican promotes gastric cancer progression via the integrin beta1-FAK signaling pathway","author":"Wang","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2017.11.024_bib0045","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/cas.12096","article-title":"Cancer-associated fibroblast and M2 macrophage markers together predict outcome in colorectal cancer patients","volume":"104","author":"Herrera","year":"2013","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.024_bib0050","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","article-title":"Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion","volume":"121","author":"Orimo","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2017.11.024_bib0055","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.biopha.2015.08.013","article-title":"miR-101 represses lung cancer by inhibiting interaction of fibroblasts and cancer cells by down-regulating CXCL12","volume":"74","author":"Zhang","year":"2015","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.biopha.2017.11.024_bib0060","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.oraloncology.2015.08.017","article-title":"Tumor necrosis factor alpha induces myofibroblast differentiation in human tongue cancer and promotes invasiveness and angiogenesis via secretion of stromal cell-derived factor-1","volume":"51","author":"Zhou","year":"2015","journal-title":"Oral Oncol."},{"issue":"13","key":"10.1016\/j.biopha.2017.11.024_bib0065","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/onc.2016.353","article-title":"Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells","volume":"36","author":"Richards","year":"2017","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.biopha.2017.11.024_bib0070","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/mc.22581","article-title":"Cancer-associated fibroblasts mediated chemoresistance by a FOXO1\/TGFbeta1 signaling loop in esophageal squamous cell carcinoma","volume":"56","author":"Zhang","year":"2017","journal-title":"Mol. Carcinog."},{"issue":"15","key":"10.1016\/j.biopha.2017.11.024_bib0075","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1038\/onc.2016.370","article-title":"Cytoplasmic GPER translocation in cancer-associated fibroblasts mediates cAMP\/PKA\/CREB\/glycolytic axis to confer tumor cells with multidrug resistance","volume":"36","author":"Yu","year":"2017","journal-title":"Oncogene"},{"issue":"37","key":"10.1016\/j.biopha.2017.11.024_bib0080","doi-asserted-by":"crossref","first-page":"59766","DOI":"10.18632\/oncotarget.11121","article-title":"Carcinoma-associated fibroblasts affect sensitivity to oxaliplatin and 5FU in colorectal cancer cells","volume":"7","author":"Goncalves-Ribeiro","year":"2016","journal-title":"Oncotarget"},{"issue":"36","key":"10.1016\/j.biopha.2017.11.024_bib0085","doi-asserted-by":"crossref","first-page":"58075","DOI":"10.18632\/oncotarget.10873","article-title":"Simultaneous activation and inhibition of autophagy sensitizes cancer cells to chemotherapy","volume":"7","author":"Chi","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.biopha.2017.11.024_bib0090","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.cell.2014.11.006","article-title":"Metabolic control of autophagy","volume":"159","author":"Galluzzi","year":"2014","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.biopha.2017.11.024_bib0095","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.cell.2013.11.019","article-title":"Autophagy-mediated tumor promotion","volume":"155","author":"Guo","year":"2013","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.biopha.2017.11.024_bib0100","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1080\/15548627.2016.1214778","article-title":"Autophagy induction for the treatment of cancer","volume":"12","author":"Pietrocola","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2017.11.024_bib0105","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.biopha.2017.07.070","article-title":"Autophagy as a potential therapeutic target during epithelial to mesenchymal transition in renal cell carcinoma: an in vitro study","volume":"94","author":"Singla","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.biopha.2017.11.024_bib0110","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/15548627.2015.1009781","article-title":"Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy","volume":"11","author":"He","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2017.11.024_bib0115","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.biopha.2017.06.011","article-title":"miR-101 Alleviates chemoresistance of gastric cancer cells by targeting ANXA2","volume":"92","author":"Bao","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.biopha.2017.11.024_bib0120","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.canlet.2015.03.045","article-title":"miR-483-5p determines mitochondrial fission and cisplatin sensitivity in tongue squamous cell carcinoma by targeting FIS1","volume":"362","author":"Fan","year":"2015","journal-title":"Cancer Lett."},{"issue":"7015","key":"10.1016\/j.biopha.2017.11.024_bib0125","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature03096","article-title":"Stromal fibroblasts in cancer initiation and progression","volume":"432","author":"Bhowmick","year":"2004","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.biopha.2017.11.024_bib0130","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.3892\/ijo.2016.3442","article-title":"Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K\/Akt signaling pathways","volume":"48","author":"Zhou","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.024_bib0135","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.18632\/oncotarget.6210","article-title":"Tumor-associated fibroblast-conditioned medium induces CDDP resistance in HNSCC cells","volume":"7","author":"Steinbichler","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.biopha.2017.11.024_bib0140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","article-title":"Autophagy in the pathogenesis of disease","volume":"132","author":"Levine","year":"2008","journal-title":"Cell"},{"issue":"7637","key":"10.1016\/j.biopha.2017.11.024_bib0145","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature20815","article-title":"Microenvironmental autophagy promotes tumour growth","volume":"541","author":"Katheder","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biopha.2017.11.024_bib0150","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1158\/0008-5472.CAN-13-2966","article-title":"The four faces of autophagy: implications for cancer therapy","volume":"74","author":"Gewirtz","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2017.11.024_bib0155","first-page":"1035","article-title":"Chloroquine enhances the efficacy of cisplatin by suppressing autophagy in human adrenocortical carcinoma treatment","volume":"10","author":"Qin","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.024_bib0160","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/15548627.2016.1239676","article-title":"GFRA1 promotes cisplatin-induced chemoresistance in osteosarcoma by inducing autophagy","volume":"13","author":"Kim","year":"2017","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.biopha.2017.11.024_bib0165","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4161\/auto.22399","article-title":"BCL2L11\/BIM: a novel molecular link between autophagy and apoptosis","volume":"9","author":"Luo","year":"2013","journal-title":"Autophagy"},{"issue":"1\u20133","key":"10.1016\/j.biopha.2017.11.024_bib0170","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejphar.2009.06.063","article-title":"Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies","volume":"625","author":"Solomon","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.11.024_bib0175","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1186\/1471-2407-10-370","article-title":"Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells","volume":"10","author":"Sasaki","year":"2010","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.biopha.2017.11.024_bib0180","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.4161\/auto.34398","article-title":"Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity","volume":"10","author":"Cicchini","year":"2014","journal-title":"Autophagy"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217349387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217349387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:28:31Z","timestamp":1780338511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217349387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":36,"alternative-id":["S0753332217349387"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.11.024","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer-associated \ufb01broblasts confer cisplatin resistance of tongue cancer via autophagy activation","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}